Cintas [CTAS] vs Rentokil Initial plc [RTO] Detailed Stock Comparison
Cintas
NASDAQ
Loading...
Rentokil Initial plc
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cintas wins in 12 metrics, Rentokil Initial plc wins in 7 metrics, with 0 ties. Cintas appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cintas | Rentokil Initial plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 48.81 | 38.33 | Rentokil Initial plc |
| Price-to-Book Ratio | 18.43 | 11.56 | Rentokil Initial plc |
| Debt-to-Equity Ratio | 56.67 | 115.51 | Cintas |
| PEG Ratio | 45.79 | 41.64 | Rentokil Initial plc |
| EV/EBITDA | 32.66 | 68.80 | Cintas |
| Profit Margin (TTM) | 17.53% | 4.46% | Cintas |
| Operating Margin (TTM) | 22.40% | 12.37% | Cintas |
| EBITDA Margin (TTM) | 22.40% | 12.37% | Cintas |
| Return on Equity | 40.27% | 5.13% | Cintas |
| Return on Assets (TTM) | 15.53% | 3.24% | Cintas |
| Free Cash Flow (TTM) | $1.76B | $626.89M | Cintas |
| Dividend Yield | 0.90% | 2.50% | Rentokil Initial plc |
| 1-Year Return | 9.63% | -25.75% | Cintas |
| Price-to-Sales Ratio (TTM) | 8.35 | 2.25 | Rentokil Initial plc |
| Enterprise Value | $88.74B | $89.71B | Rentokil Initial plc |
| EV/Revenue Ratio | 8.58 | 11.97 | Cintas |
| Gross Profit Margin (TTM) | 49.71% | N/A | N/A |
| Revenue per Share (TTM) | $26 | $11 | Cintas |
| Earnings per Share (Diluted) | $4.39 | $0.63 | Cintas |
| Beta (Stock Volatility) | 1.02 | 0.33 | Rentokil Initial plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cintas vs Rentokil Initial plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cintas | -0.25% | -2.37% | -2.35% | -2.23% | 5.71% | 18.68% |
| Rentokil Initial plc | 0.91% | -3.86% | 1.68% | 3.96% | -4.73% | -3.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cintas | 9.63% | 105.82% | 158.91% | 912.70% | 3,276.72% | 1,990.04% |
| Rentokil Initial plc | -25.75% | -22.18% | -32.26% | 114.46% | 219.29% | 219.29% |
Performance & Financial Health Analysis: Cintas vs Rentokil Initial plc
| Metric | CTAS | RTO |
|---|---|---|
| Market Information | ||
| Market Cap | $86.35B | $12.46B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,340,040 | 850,249 |
| 90 Day Avg. Volume | 1,408,220 | 866,943 |
| Last Close | $215.58 | $24.39 |
| 52 Week Range | $180.78 - $229.24 | $19.60 - $34.07 |
| % from 52W High | -5.96% | -28.41% |
| All-Time High | $229.24 (Jun 06, 2025) | $43.69 (Nov 08, 2021) |
| % from All-Time High | -5.96% | -44.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.03% |
| Quarterly Earnings Growth | 0.08% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.04% |
| Operating Margin (TTM) | 0.22% | 0.12% |
| Return on Equity (TTM) | 0.40% | 0.05% |
| Debt to Equity (MRQ) | 56.67 | 115.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.63 | $2.09 |
| Cash per Share (MRQ) | $0.66 | $0.67 |
| Operating Cash Flow (TTM) | $2.17B | $1.02B |
| Levered Free Cash Flow (TTM) | $1.56B | $419.56M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.90% | 2.50% |
| Last 12-Month Dividend | $2.01 | $0.58 |
Valuation & Enterprise Metrics Analysis: Cintas vs Rentokil Initial plc
| Metric | CTAS | RTO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 48.81 | 38.33 |
| Forward P/E | 45.79 | 41.64 |
| PEG Ratio | 45.79 | 41.64 |
| Price to Sales (TTM) | 8.35 | 2.25 |
| Price to Book (MRQ) | 18.43 | 11.56 |
| Market Capitalization | ||
| Market Capitalization | $86.35B | $12.46B |
| Enterprise Value | $88.74B | $89.71B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.58 | 11.97 |
| Enterprise to EBITDA | 32.66 | 68.80 |
| Risk & Other Metrics | ||
| Beta | 1.02 | 0.33 |
| Book Value per Share (MRQ) | $11.63 | $2.09 |
Financial Statements Comparison: Cintas vs Rentokil Initial plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CTAS | RTO |
|---|---|---|
| Revenue/Sales | $2.67B | N/A |
| Cost of Goods Sold | $1.34B | N/A |
| Gross Profit | $1.33B | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $597.45M | N/A |
| EBITDA | $721.36M | N/A |
| Pre-Tax Income | $575.42M | N/A |
| Income Tax | $127.16M | N/A |
| Net Income (Profit) | $448.26M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CTAS | RTO |
|---|---|---|
| Cash & Equivalents | $263.97M | $1.23B |
| Total Current Assets | $3.44B | $2.82B |
| Total Current Liabilities | $1.64B | $3.48B |
| Long-Term Debt | $2.60B | $3.80B |
| Total Shareholders Equity | $4.68B | $5.72B |
| Retained Earnings | $11.80B | $4.88B |
| Property, Plant & Equipment | $3.50B | $827.45M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CTAS | RTO |
|---|---|---|
| Operating Cash Flow | $599.12M | N/A |
| Capital Expenditures | $0 | N/A |
| Free Cash Flow | $521.13M | N/A |
| Debt Repayment | $-450.00M | N/A |
| Common Stock Repurchase | $-256.67M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CTAS | RTO |
|---|---|---|
| Shares Short | 5.50M | 2.24M |
| Short Ratio | 3.74 | 2.61 |
| Short % of Float | 0.02% | 0.00% |
| Average Daily Volume (10 Day) | 1,340,040 | 850,249 |
| Average Daily Volume (90 Day) | 1,408,220 | 866,943 |
| Shares Outstanding | 402.95M | 3.40B |
| Float Shares | 342.24M | 2.28B |
| % Held by Insiders | 0.15% | 0.00% |
| % Held by Institutions | 0.67% | 0.13% |
Dividend Analysis & Yield Comparison: Cintas vs Rentokil Initial plc
| Metric | CTAS | RTO |
|---|---|---|
| Last 12-Month Dividend | $2.01 | $0.58 |
| Last 12-Month Dividend Yield | 0.90% | 2.50% |
| 3-Year Avg Annual Dividend | $1.51 | $0.53 |
| 3-Year Avg Dividend Yield | 0.22% | 0.88% |
| 3-Year Total Dividends | $4.53 | $1.58 |
| Ex-Dividend Date | Aug 15, 2025 | Apr 04, 2025 |